May 16, 2025

FDA Approves PD-1–Targeted Monoclonal Antibody for SCAC

The FDA has approved Zynyz (retifanlimab-dlwr) as the first programmed death receptor-1 inhibitor for first-line treatment of advanced squamous cell carcinoma of the anal canal.

Conexiant

May 16, 2025

Long-Term Data Support BCT for BRCA-Mutated Breast Cancer

Researchers found that breast-conserving treatment provided long-term survival outcomes comparable to mastectomy in patients with breast cancer and BRCA1 or BRCA2 pathogenic variants.

Conexiant

May 15, 2025

Assistant Professor Salary Gaps Persist Nationwide

Persistent salary disparities by gender, race, and ethnicity were identified among more than 45,000 U.S. assistant professors, with underrepresented in medicine women learning the least across all specialties.

Conexiant

May 14, 2025

Pneumomediastinum After Dental Cleaning: What's Your Diagnosis?

A rare case of pneumomediastinum and subcutaneous emphysema following dental cleaning requires high-flow oxygen therapy rather than invasive interventions. Learn why.

Conexiant

May 14, 2025

Leading Cause of Death in Residents, Study

Study shows high suicide rates during training transitions, with pathology residents facing the highest suicide risk compared with other specialties.

Conexiant

May 13, 2025

Appendectomy Cuts UC Relapse Rates, Study

Appendicectomy may significantly reduce relapse rates within 1.

Conexiant

May 09, 2025

Mediastinitis Carries Highest Death Risk Postsurgery

Mediastinitis leads to the highest risk of death within 90 days after surgery.

Conexiant

May 07, 2025

Pancreatitis Prevention: Just a Myth?

A major study finds no benefit from a common surgery long used to prevent pancreatitis.

Reuters

May 06, 2025

New SCIA Flap Option Shows Safe Results

A new breast reconstruction technique using the superficial branch of the SCIA flap showed safe outcomes in 4 women, offering an alternative to DIEP flaps with less abdominal trauma.

Conexiant